HomeC6K0 • FRA
add
Avalo Therapeutics Inc
Previous close
€4.01
Day range
€3.98 - €3.98
Year range
€3.00 - €13.50
Market cap
52.30M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.76M | 80.89% |
Net income | -13.15M | 89.16% |
Net profit margin | — | — |
Earnings per share | -1.29 | — |
EBITDA | -14.53M | -179.77% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 125.05M | 13.50% |
Total assets | 138.52M | 11.96% |
Total liabilities | 15.91M | -92.92% |
Total equity | 122.62M | — |
Shares outstanding | 10.83M | — |
Price to book | 0.35 | — |
Return on assets | -25.36% | — |
Return on capital | -28.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.15M | 89.16% |
Cash from operations | -9.46M | -52.48% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -9.46M | -109.20% |
Free cash flow | -4.65M | -102.23% |
About
Founded
2011
Headquarters
Website
Employees
23
